Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Almquist

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Laboratory Animal Science|April 1, 1992
Activation of B virus (Herpesvirus simiae) in chronically immunosuppressed cynomolgus monkeysG J Chellman, V S Lukas, E M Eugui, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitorJugnu Jain, Susan J Almquist, Angela D Heiser, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2016
Unraveling the pharmacokinetic interaction of ticagrelor and MEDI2452 (Ticagrelor antidote) by mathematical modelingJ Almquist, M Penney, S Pehrsson, et al.
Journal of Thrombosis and Haemostasis : JTH|March 22, 2017
Hemostatic effects of the ticagrelor antidote MEDI2452 in pigs treated with ticagrelor on a background of aspirinS Pehrsson, K J Johansson, A Janefeldt, et al.
Transplantation Proceedings|April 1, 1991
Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allograftsR E Morris, J Wang, J R Blum, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 12, 2008
Baseline evaluation of routine HIV testing among tuberculosis patients in BotswanaV M Gammino, J J Mboya, T Samandari, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine proteaseRobert B Perni, Susan J Almquist, Randal A Byrn, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Laboratory Animal Science|April 1, 1992
Activation of B virus (Herpesvirus simiae) in chronically immunosuppressed cynomolgus monkeysG J Chellman, V S Lukas, E M Eugui, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitorJugnu Jain, Susan J Almquist, Angela D Heiser, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2016
Unraveling the pharmacokinetic interaction of ticagrelor and MEDI2452 (Ticagrelor antidote) by mathematical modelingJ Almquist, M Penney, S Pehrsson, et al.
Journal of Thrombosis and Haemostasis : JTH|March 22, 2017
Hemostatic effects of the ticagrelor antidote MEDI2452 in pigs treated with ticagrelor on a background of aspirinS Pehrsson, K J Johansson, A Janefeldt, et al.
Transplantation Proceedings|April 1, 1991
Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allograftsR E Morris, J Wang, J R Blum, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 12, 2008
Baseline evaluation of routine HIV testing among tuberculosis patients in BotswanaV M Gammino, J J Mboya, T Samandari, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine proteaseRobert B Perni, Susan J Almquist, Randal A Byrn, et al.
Pageof 3